|
|
Office Locations:
|
55 William St., Suite 240
Wellesley, MA 02481
Phone: 781-239-0700
Fax: 781-239-0824
| |
|
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Ampersand, a middle market private equity firm focused on investments in two core sectors: Healthcare and industrial. The firm targets middle market, growth equity opportunities where it is the first institutional investor. Ampersand's investment team consists of almost 20 professionals managing more than $600 million from the firm's offices in Wellesley, MA. Ampersand originated in 1969 as an internal, technology-focused venture capital investment activity at PaineWebber. Ampersand was then founded in 1988 as a spinoff from PaineWebber, focused on the specialty materials and chemicals (SMC) industry. Over the past two decades Ampersand has managed $1 billion in private equity partnerships. Ampersand targets companies with $10 to $100 million of revenue.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
